BCRA

BRCA1 and BRCA2 mutations are not just linked to breast and ovarian cancer—they also increase the risk of pancreatic cancer. Canadians with a BRCA1/2 mutation have a higher chance of developing pancreatic cancer, making genetic testing crucial for early detection and treatment. Understanding BRCA mutations can open doors to targeted therapies like PARP inhibitors and personalized treatment strategies. Learn how BRCA testing can impact pancreatic cancer care and why it matters for families.